ライフサイエンスコーパス: morbidity

1 s remains associated with high mortality and morbidity.

2 moderate the effect of mosquito exposure on morbidity.

3 rotected offspring from long-term behavioral morbidity.

4 tment for DBA is associated with significant morbidity.

5 ciated with increased risk for mortality and morbidity.

6 nt data to analyze other markers of neonatal morbidity.

7 nct subtypes of pathophysiology and clinical morbidity.

8 lbirth, neonatal complications and adulthood morbidity.

9 an be harvested and cause minimal donor site morbidity.

10 ding the origins of senescence, frailty, and morbidity.

11 tion of NF1 and can cause significant visual morbidity.

12 exposure, was associated with greater asthma morbidity.

13 atohepatitis and is a major cause of hepatic morbidity.

14 easles antibody concentrations and increased morbidity.

15 levated cardiovascular disease mortality and morbidity.

16 ganglioneuroma and therefore limit surgical morbidity.

17 ributor to short and long-term postoperative morbidity.

18 haracterized by joint destruction and severe morbidity.

19 with poor glycemic control and increased T2D morbidity.

20 iable risk factor for neonatal mortality and morbidity.

21 that is associated with a high mortality and morbidity.

22 ve shown stress may lead to diabetes-related morbidities.

23 corticosteroid treatment causes significant morbidities.

24 sed susceptibility to severe immune-mediated morbidities.

25 her smoking traits (r(g) = 0.40-1.09) and co-morbidities.

26 tal delay with a wide range of additional co-morbidities.

27 the elderly and people with pre-existing co-morbidities.

28 UCTs did not impact on reported child morbidity 2 week's prior to report (DD = -3.5 pp, ROR: 0

29 pe 2 diabetes delays diagnosis and increases morbidity(2).

30 sisted, and hybrid MIPD had comparable major morbidity (27% vs 27% vs 35%), POPF (24% vs 19% vs 25%),

31 Persistent respiratory morbidity a priori defined as a respiratory PedsQL, a pe

32 tside of the Northeast, increased medical co-morbidities, a history of depression, anxiety, substance

33 s for only a small fraction of mortality and morbidity acceleration and hence is unlikely to be causa

34 ions are the most common driver of long-term morbidity after abdominal surgery.

35 omic status, medication history, systemic co-morbidities, alcohol or tobacco use as well as serum lev

36 d substantially, but long-term mortality and morbidity among children initially surviving sepsis, is

37 ea is common and associated with substantial morbidity among hematopoietic cell transplant (HCT) reci

38 ther the use of an LMA reduces mortality and morbidity among neonates with asphyxia is unknown.

39 xic CD4 T cells are linked to cardiovascular morbidities and accumulate in both HIV and CMV infection

40 ms of demographics, lifestyle factors and co-morbidities and cardiovascular risk factors/diseases wer

41 melioidosis is a bacterial disease with high morbidity and a mortality rate that can be as high as 40

42 oration provides a near complete recovery of morbidity and a significant extension of lifespan; howev

43 nical complications of rupture, harvest site morbidity and biocompatibility associated with autograft

44 Allergic asthma causes substantial morbidity and constitutes a public health burden, which

45 ematic to diagnose and may cause significant morbidity and death from heart failure or ventricular ar

46 ten progresses to dementia, a major cause of morbidity and disability.

47 They cause significant morbidity and draw on health-care resources.

48 ns are costly to treat, causing considerable morbidity and early mortality.

49 ney injury is common, with a major effect on morbidity and health care utilization.

50 patients and is associated with substantial morbidity and high medical costs.

51 tudy was to characterize COVID-19-associated morbidity and in-hospital mortality by race/ethnicity.

52 triction (IUGR) is associated with perinatal morbidity and increased risk of lifelong disease, includ

53 h is a major cause of neonatal mortality and morbidity and leads to preterm premature rupture of plac

54 esulting from trauma or diseases, donor site morbidity and limited availability restrict their use.

55 addition to adverse trends in stroke-related morbidity and mortality across the broader population, t

56 disease (GVHD) remains an important cause of morbidity and mortality after allogeneic hematopoietic c

57 on-based study aimed to report postoperative morbidity and mortality after esophagectomy and gastrect

58 nths of malaria chemoprevention could reduce morbidity and mortality after hospital discharge in chil

59 entricular failure (RVF) is a cause of major morbidity and mortality after left ventricular assist de

60 Liver disease is a leading cause of morbidity and mortality among Human Immunodeficiency vir

61 ed Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not

62 on of sepsis, is associated with substantial morbidity and mortality and lacks definitive disease-mod

63 arcinoma (HNSCC) is a disease of significant morbidity and mortality and rarely diagnosed in early st

64 wn prognostic factors survival is varied and morbidity and mortality are relatively high.

65 mic proportions causing remarkably increased morbidity and mortality around the world.

66 t cell-mediated immunity.IMPORTANCE The high morbidity and mortality associated with clinical cases o

67 issibility of the virus and the high rate of morbidity and mortality associated with COVID-19, develo

68 as aeruginosa is responsible for much of the morbidity and mortality associated with cystic fibrosis

69 Compared to published reports on the morbidity and mortality associated with SARS-CoV-2, toci

70 Morbidity and mortality burden from these conditions was

71 curate and rapid identification may decrease morbidity and mortality by allowing for aggressive clini

72 us disease 2019 (COVID-19) exhibit increased morbidity and mortality compared with individuals withou

73 buting to chronic inflammation and increased morbidity and mortality during antiretroviral-treated HI

74 onal influenza virus is associated with high morbidity and mortality especially in vulnerable patient

75 used country-specific or WHO region-specific morbidity and mortality estimates and distributed them s

76 indices are ineffective predictors of 30-day morbidity and mortality for patients undergoing high-ris

77 erventional coronary reperfusion strategies, morbidity and mortality from acute myocardial infarction

78 NAFLD is associated with significant morbidity and mortality from cirrhosis, hepatocellular c

79 conditions may even overshadow the projected morbidity and mortality from coronavirus disease 2019 (C

80 with PID and symptomatic SID display greater morbidity and mortality from COVID-19.

81 es and recipients are at risk of significant morbidity and mortality from infection, including those

82 llocation for interventions to reduce severe morbidity and mortality from RSV in this age group.

83 RTANCE Ebola outbreaks result in significant morbidity and mortality in affected countries.

84 lar dystrophy (DMD) is an important cause of morbidity and mortality in affected males with this drea

85 onsiderable reductions in malaria-associated morbidity and mortality in Africa since the beginning of

86 CMV) infection remains an important cause of morbidity and mortality in allogeneic hematopoietic cell

87 ic inflammation and potentially exacerbating morbidity and mortality in children living with HIV.

88 Hypokalemia is associated with excess morbidity and mortality in heart failure.

89 ications as VO2 peak is highly predictive of morbidity and mortality in HF.

90 lar, pulmonary disease is a leading cause of morbidity and mortality in individuals with RA.

91 be key elements to improving post-discharge morbidity and mortality in LMICs.

92 spergillosis (IPA) is a significant cause of morbidity and mortality in lung transplant recipients (L

93 re shown to reduce and prevent virus-induced morbidity and mortality in mice upon prophylactic admini

94 The primary cause of morbidity and mortality in patients with multiple myelom

95 recovery are associated with an increase in morbidity and mortality in patients.

96 birth defects and an etiology of significant morbidity and mortality in solid organ and hematopoietic

97 coronary artery disease is a major cause of morbidity and mortality in the developed world.

98 Cancer is one of the leading causes of morbidity and mortality in the globe.

99 HCC as a cause of morbidity and mortality in the HBV/HIV co-infected patie

100 ion control are key to help prevent COVID-19 morbidity and mortality in these high-risk populations.

101 ntiviral therapeutics are important to limit morbidity and mortality in those already infected.

102 Substantial morbidity and mortality occurred among IC adults hospita

103 Major morbidity and mortality occurred in 17.1% and 1.7% of pa

104 an initial step toward mitigating the excess morbidity and mortality of an incarceration event.

105 to many critical conditions ranging from the morbidity and mortality of critically ill patients to th

106 sses by diminished egg quality and increased morbidity and mortality of infected animals.

107 nfection (CDI) is associated with increasing morbidity and mortality posing an urgent threat to publi

108 s circulation is associated with significant morbidity and mortality post abdominal surgery, irrespec

109 r corrected) did not improve the accuracy of morbidity and mortality prediction.

110 re and despite advanced therapeutic options, morbidity and mortality rates remain high.

111 Disease morbidity and mortality remain high, with a 5-year survi

112 Developing effective therapies to reduce morbidity and mortality requires knowing the responsible

113 Postoperative morbidity and mortality were 38% and 2%, respectively.

114 Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increa

115 serovar Typhi (S. Typhi) causes substantial morbidity and mortality worldwide, particularly among yo

116 us system (CNS) infections cause substantial morbidity and mortality worldwide, with mounting concern

117 w to control a virus that causes significant morbidity and mortality worldwide.

118 fections (ALRIs), with significant childhood morbidity and mortality worldwide.

119 and is a significant cause of cardiovascular morbidity and mortality worldwide.

120 sease (CVD) and cancer are leading causes of morbidity and mortality worldwide.

121 ary artery disease (CAD) is a major cause of morbidity and mortality worldwide.

122 Despite reductions in morbidity and mortality, a growing patient population is

123 Diphtheria, once a major cause of childhood morbidity and mortality, all but disappeared following i

124 ponsible for an enormous amount of worldwide morbidity and mortality, and each has evolved specialize

125 fractures are associated with a high rate of morbidity and mortality, and successful ambulation after

126 (IFIs) is critical due to the high rates of morbidity and mortality, as well as the substantial econ

127 homeostasis are associated with significant morbidity and mortality, but a fundamental understanding

128 of respiratory virus infections, increasing morbidity and mortality, but can be readily treated if d

129 infections are a major cause of respiratory morbidity and mortality, especially in patients with pre

130 e men have poor overall health and increased morbidity and mortality, increased rates of both genitou

131 luding overall mortality, and liver-specific morbidity and mortality, respectively.

132 myocardial injury remains a major driver of morbidity and mortality, the ability to accurately ident

133 prevent and treat virus infections to limit morbidity and mortality, the continued emergence and re-

134 gh obesity is an established risk factor for morbidity and mortality, the minimum amount of weight lo

135 nterrupting psychiatric conditions with high morbidity and mortality, yet the basic mechanisms underl

136 warranted in order to curb iatrogenic opioid morbidity and mortality.

137 d is known to be associated with significant morbidity and mortality.

138 severe infection associated with significant morbidity and mortality.

139 the elderly population, causing significant morbidity and mortality.

140 s), as it has been associated with increased morbidity and mortality.

141 Prostate cancer is a major cause of cancer morbidity and mortality.

142 common preventable cancers with the highest morbidity and mortality.

143 nd causes significant maternal and perinatal morbidity and mortality.

144 is becoming a significant cause of worldwide morbidity and mortality.

145 ety of diseases and continues to harbor high morbidity and mortality.

146 clinical studies aimed at reducing COVID-19 morbidity and mortality.

147 uenza contributes significantly to childhood morbidity and mortality.

148 Influenza infection causes substantial morbidity and mortality.

149 2019 pandemic resulting in significant human morbidity and mortality.

150 ents were the key determinants of subsequent morbidity and mortality.

151 ith its metastasis leading to cancer-related morbidity and mortality.

152 ult in frequent hospital admissions and high morbidity and mortality.

153 infection and is associated with significant morbidity and mortality.

154 e strains associated with increased rates of morbidity and mortality.

155 cardiac arrhythmia and cause of significant morbidity and mortality.

156 Overweight and obesity increase the risk of morbidity and mortality.

157 ema is common, and fractures have associated morbidity and mortality.

158 ters can significantly reduce stroke-related morbidity and mortality.

159 e of beta-blockers was associated with lower morbidity and mortality.

160 transplantation is associated with increased morbidity and mortality.

161 mens and allograft failure cause significant morbidity and mortality.

162 virus (HSV) disease results in unacceptable morbidity and mortality.

163 has driven breakthroughs in reducing malaria morbidity and mortality.

164 tes hemorrhage and is associated with higher morbidity and mortality.

165 Venous thromboembolism is a major cause of morbidity and mortality.

166 major public health concern with substantial morbidity and mortality.

167 pancreatitis is associated with substantial morbidity and mortality.

168 tem tumors, which are associated with excess morbidity and mortality.

169 geneous cancer with widely varying levels of morbidity and mortality.

170 e risk factor associated with cardiovascular morbidity and mortality.

171 is a costly problem leading to readmissions, morbidity and mortality.

172 ntially leads to an increased risk of asthma morbidity and mortality.

173 n high-income countries to prevent perinatal morbidity and mortality.

174 tive endocarditis (IE)-a condition with high morbidity and mortality.

175 toxins are associated with significant human morbidity and mortality.

176 omy in adults is associated with significant morbidity and mortality.

177 line laparotomy is associated with increased morbidity and mortality.

178 part of critical care that directly affects morbidity and mortality.

179 Metastases cause a vast majority of cancer morbidity and mortality.

180 ure (BP) is a risk factor for cardiovascular morbidity and mortality.

181 tially severe extracutaneous manifestations, morbidity and mortality.

182 very and contribute substantially to overall morbidity and mortality.

183 thus causing serious bleeding and increased morbidity and mortality.

184 rectal cancer is associated with substantial morbidity and mortality.

185 indicate that a cytokine storm may increase morbidity and mortality.

186 -19) pandemic is associated with substantial morbidity and mortality.

187 mised and may be vulnerable to COVID-related morbidity and mortality.

188 smoking is the leading cause of preventable morbidity and mortality.

189 more highly transmissible and causing higher morbidity and mortality.

190 rome coronavirus 2, resulting in significant morbidity and mortality.

191 e-associated bloodstream infection with high morbidity and mortality.

192 esponsible for almost all malaria-associated morbidity and mortality.

193 tastases given the potential for significant morbidity and mortality.

194 Heart failure (HF) is a major source of morbidity and mortality.

195 sociated with significant risk of limb loss, morbidity and mortality; however, there remains unmet th

196 cosal inflammation correlates with increased morbidity and poor clinical outcomes among patients livi

197 ical conditions that contribute to increased morbidity and premature death.

198 upation, is associated with risk for disease morbidity and psychopathology.

199 chronic disease with significant associated morbidity and socioeconomic impact, is undergoing a know

200 ggest a prevalence of persistent respiratory morbidity and the association between positive bacterial

201 ithout CKD, but the magnitude of this excess morbidity and the factors associated with hospitalizatio

202 Given the severe morbidity and the mortality associated with thrombotic d

203 tal quality scores, and levels of patient co-morbidity), and analysed cost-effectiveness.

204 matrix, which can lead to organ dysfunction, morbidity, and death.

205 s led to ineffective treatments, significant morbidity, and high mortality rates for patients with ne

206 The mortality, morbidity, and long-term outcomes were evaluated retrosp

207 reased risk for chronic disease development, morbidity, and mortality among food-insecure households

208 ly contribute to overall malaria prevalence, morbidity, and onwards transmission.

209 ctomy as well as its definitions, technique, morbidity, and outcomes.

210 to end-stage kidney failure, cardiovascular morbidity, and premature death.

211 s chronicity, contribution to disability and morbidity, and prevalence of more than 2%, the effective

212 Neonatal morbidities are associated with long term neurological d

213 life-threatening risks or lead to long-term morbidity are gaining increasing importance.

214 r-associated osteolysis and prevent skeletal morbidity as well as use of appropriate local treatments

215 l ventilation predict persistent respiratory morbidity at follow-up.

216 that resection carried a substantial risk of morbidity because of the potential need to sacrifice the

217 4%, 74/303) was not associated with other co-morbidities (but high refusal in rural clinics).

218 sroom NO(2) exposure and asthma symptoms and morbidity by body mass index (BMI) category.

219 Severe maternal morbidity, chronic health conditions, health care encoun

220 on combined with routinely collected malaria morbidity data from the town of Mancio Lima, the main ur

221 The authors used national morbidity data to investigate the association between sh

222 Mortality and morbidity data were collected by telephone, at home visi

223 The overall rates of death or serious morbidity (DSM) and clinically-relevant fistula (CR-POPF

224 at exposure and cause-specific mortality and morbidity [e.g., circulatory deaths, odds ratio per 5 de

225 s of neurological sequelae: neuropsychiatric morbidities, educational landmarks, use of hospital serv

226 a more effective treatment, lower associated morbidity, fewer false-positive and false-negative resul

227 SSIs are a common cause of morbidity following open abdominal surgery.

228 plications are important causes of death and morbidity following preterm birth.

229 mortality and health-related quality of life morbidity for children encountering community-acquired s

230 rate of laparoscopic surgery, mortality and morbidity for colorectal cancer resections by Lapco dele

231 improved survival, albeit with considerable morbidity from glucocorticoids and other immunosuppressi

232 ing causes of vaccine-preventable deaths and morbidity globally.

233 od are commons causes of chronic respiratory morbidity globally.

234 OVID-19 had increased probability of serious morbidity, healthcare seeking, hospitalization, and abse

235 As a leading cause of death and morbidity, heart failure (HF) is responsible for a large

236 ect was measured between ITN use and malaria morbidity; however, ITN use did moderate the effect of m

237 3 (1.9%) patients and composite mortality or morbidities in 72 (46.5%).

238 bacterial respiratory culture and pulmonary morbidity in a population of only previously healthy chi

239 cular and kidney complications that increase morbidity in adults.

240 is is the most common source of neurological morbidity in cancer patients.

241 Enteric fever remains a major cause of morbidity in developing countries with poor sanitation c

242 tal cancer surgery and reduced mortality and morbidity in England.

243 al targets for the management of this severe morbidity in head and neck cancer patients.

244 ial virus (RSV) infection causes significant morbidity in hematopoietic cell transplant (HCT) recipie

245 The Copenhagen Co-Morbidity in HIV Infection study included 453 participan

246 , shoulder dystocia, and associated neonatal morbidity in low- and mixed-risk populations.

247 symptoms, and serologic responses that cause morbidity in patients and concern in treating clinicians

248 is unknown if beta-blockers reduce mortality/morbidity in patients with heart failure (HF) and advanc

249 s (TB) is the leading cause of mortality and morbidity in people living with human immunodeficiency v

250 incidence was low but generated significant morbidity in PLHIV.

251 (fibroids) are a major source of gynecologic morbidity in reproductive age women and are characterize

252 medical emergency causing high mortality and morbidity in rural tropical communities that typically e

253 d with reduced IPTp-SP efficacy and enhanced morbidity in SP recipients.

254 ceptibility to infection, a leading cause of morbidity in those living with SCI.

255 t a higher risk of early-life infections and morbidities including dental disease.

256 evalent disorder associated with significant morbidity, including the development of epilepsy and mor

257 risk of perinatal death and severe neonatal morbidity increases gradually after 41 weeks of pregnanc

258 The Charlson Co-Morbidity Index was a fourth measure of frailty.

259 a severe and fatal neurological disease, but morbidity is vaccine preventable and treatable prior to

260 rhoea, a global cause of child mortality and morbidity, is linked to adverse consequences including c

261 ment further highlights the need to scale up morbidity management programs.

262 vel the postoperative mortality (POM), major morbidity (MM) and failure-to-rescue (FTR) after cytored

263 y was to investigate the long-term survival, morbidity, mortality and pathology results in patients f

264 regard to long-term survival, postoperative morbidity, mortality and pathology results.

265 c disorder associated with marked suffering, morbidity, mortality, and cost.

266 vascular disease (CVD) is the major cause of morbidity, mortality, and health care costs in the Unite

267 c arrhythmia, is associated with substantial morbidity, mortality, and healthcare use.

268 annually, no differences were found in major morbidity, mortality, and hospital stay between MIPD and

269 r risk, (2) interhuman transmission, and (3) morbidity/mortality associated with infections based on

270 rus infections, with an exceptionally higher morbidity observed with chikungunya virus (CHIKV).

271 erative day 7 strongly predicted high 90-day morbidity (odds ratio 3.96 per 10 CCI points, P < 0.001)

272 /group), MaSBO was associated with increased morbidity [odds ratio (OR) 1.2, P = 0.004], but not read

273 MM was defined as at least 3 coexistent morbidities of high blood pressure, diabetes mellitus, o

274 the Meox2-Cre driver, female pups exhibit no morbidity or mortality despite partial X reactivation.

275 ine whether different degrees of severity in morbidity or mortality failed to be statistically signif

276 over- or under-treatment that may result in morbidity or mortality.

277 s study investigated all-cause mortality and morbidity outcomes of LD compared with a healthy cohort.

278 No study reported neonatal deaths, maternal morbidity, preterm births, or low birthweight.

279 tal meningitis results in high mortality and morbidity rates for those affected.

280 nt have led to a decline in mortality rates, morbidity rates have remained relatively unchanged.

281 We consider how co-morbidities related to an aging and damaged soma can hin

282 restore quality of life and body image, its morbidity remains substantial.

283 bisphenol F (BPF) is associated with asthma morbidity remains unknown.

284 and main concerns include high postoperative morbidity, requirement of advanced surgery, and pelvic r

285 nger survival, blood loss, bile leakage, and morbidity should be reduced.

286 es of maternal mortality and severe maternal morbidity (SMM) are higher in the United States than in

287 We propose that additional sex-dependent co-morbidities, such as chronic stress, protein misfolding,

288 tion has higher patient acceptance and lower morbidity than intraocular injection, but many ophthalmi

289 s or investigate environmental factors or co-morbidities that may trigger the pathogenic process.

290 onor nephrectomy (HALDN) confers significant morbidity to a healthy patient group.

291 postnatal alveolar development and increased morbidity to respiratory infections, had reduced IGF1 co

292 promising advantages include reduced patient morbidity, unlimited graft availability, and comparable

293 The role of co-morbidities was strongly influenced by the dominant effe

294 Predicted morbidity was calculated using the American College of S

295 Morbidity was significant independent prognostic factors

296 Neurological morbidities were assessed with longitudinal event depict

297 ne responses limit pathogen-induced cellular morbidity, which can facilitate the establishment of rap

298 crovascular supply, regardless of disease co-morbidities, will assist recovery of exercise tolerance

299 n obesity results in increased mortality and morbidity, with contributions to cardiovascular disease,

300 ry artery disease (CAD) causes mortality and morbidity worldwide.